Background The long-time exercise test (ET) is used to diagnose the primary periodic paralyses (PPs). However the reference values of ET are many and various. This study aimed to investigate the reference value of long-time ET in the diagnosis of PPs. Methods We recruited 108 healthy subjects, 68 patients with PPs, and 72 patients with other diseases for the study. The procedure of ET was made on the basis of the McManis' method. Electrical responses were recorded from right abductor digiti minimi (ADM) muscle when stimulation of the ulnar nerve at the wrist. After the compound muscle action potential (CMAP) was monitored, subjects were then asked to contract the muscle as strongly as possible for 5 minutes. CMAPs were recorded for 2 seconds immediately after cessation of exercise, then every 5 minutes for 10 minutes, and finally every 10 minutes for 50 minutes. In general, the CMAP amplitudes will fall below the pre-exercise levels in an hour. The largest decrease was calculated and used as results of ET. Results The CMAP amplitude decreases had no significant differences between groups when the healthy adults were grouped according to age, gender, height, weight and test time. Decreases in PPs patients (57.76%) were significantly more than in healthy subjects (15.21%) and other disease patients (18.10%, P <0.001). Receiver operating characteristic (ROC) curve analysis showed that the best threshold is 35.50%. Conclusions In the long-time exercise test, threshold of 35.50% for the CMAP amplitude decrease was identified for abnormal. The result is not influenced by age, gender, height, weight, and test time. About 7.4% of healthy subjects were abnormal in ET.
P eriodic para lyses (PPs) are a group of rare, heterogeneous disorders, clinically characterized by episodic, sudden onset, flaccid paralysis of a single, several or all skeletal muscles with usually complete recovery between the attacks. 1 Symptoms may not appear when patients came to the hospital, so diagnosis may be difficult.
The long-time exercise test (ET) is a workup to help diagnosis. The PPs patients were found to have larger decrease in the compound muscle action potential (CMAP) amplitude after five-minute exercise than healthy adults. Lots of studies have indicated that the ET is a useful and sensitive diagnostic test for PPs. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] However, the reference range of ET varies. The threshold of CMAP amplitude decrease rate was between 20% and 40%. 4, 5, 8, 12, 13 The reference range was defined as the mean ± 2 standard deviations (SD) for control subjects. Few studies used receiver operator characteristic (ROC) curves to explore the threshold. The number of control subjects was small. In addition, there may be several factors that can affect the result, for example age, gender, test time of day, height, and weight. Furthermore, control subjects should be patients rather than healthy adults. Our study was to overcome the above shortcomings and find a rational reference value of ET.
METHODS

Patients and control subjects
Between March 3, 2006 and March 18, 2008, we recruited prospectively 108 healthy adults, 68 PPs patients, 72 other patients who had the clinical features like PPs from the Peking Union Medical College Hospital (PUMCH). The PUMCH appropriate institutional review board had approved the project. All participants gave informed consent.
One hundred and eight healthy subjects all had neurologic examinations and had no sign of neuromuscular disorders. No one had a history of PPs in his family members. Participants were categorized according to age. We randomly ran tests at 8 a.m., 10 a.m., 12 noon, 2 p.m., or 4 p.m. The age, gender, height and weight of healthy adults were recorded.
The clinical diagnosis of PPs was ambiguous in the literatures because of no gold standard. We made the inclusion criteria of our study on the basis of Venance SL's review about PPs. 3 The inclusion criteria included: (1) a history of transient episodes of weakness; (2) the episodes may have had weakness-inducing factors (e.g., vigorous exercise or carbohydrate-rich meals); (3) abnormal or normal serum potassium levels; (4) assessment of thyroid status is normal; (5) exclusion of secondary causes of weakness; (6) possibility of PP family history; (7) may have mutations in gene CACNA1S and SCN4A. All 68 PPs patients met the diagnostic criteria 1-5, but only 1 patient met the criteria 6-7. He has a family history of PPs and mutations in CACNA1S.
The other patients group included subjects with various diseases. They came to the hospital because of all kinds of weaknesses on limbs. The neurologist excluded the the diagnosis of PPs after some laboratory examination and electromyogram (EMG). Eighteen patients in this group had myopathies (5 with myasthenia gravis (MG), 2 with Lambert-Eaten myasthenic syndrome (LEMS), 2 with polymyositis and the remaining, 9 with various other myopathies). Twelve patients had neuropathies (5 with Guillain-Barre syndrome (GBS), 1 with amyotrophic lateral sclerosis (ALS), 1 diabetic neuropathy, and the remaining 5 with various other neuropathies). Two patients finally were diagnosed transient ischemic attack (TIA). Fourteen patients had definitely anxiety disorder. Twenty-six patients were with unknown causes for weakness. There were no patients with hyperthyreosis in this group.
Electromyography procedure
Our study chose the long-time ET procedure described by McManis et al, 4 but had some changes. CMAPs were evoked by supramaximal nerve stimulation and recorded using skin electrodes. Electrical responses were recorded from right abductor digiti minimi (ADM) muscle after stimulation of the ulnar nerve at the wrist. Recording electrodes consisted of a pair of small discs carefully positioned to ensure maximal CMAP amplitude. Supramaximal stimulation (single stimulation 0.3 millisecond in duration, and of a stimulation intensity 20%-30% greater than that required to evoke maximal CMAP amplitude) of the ulnar nerve was performed using a bipolar bar electrode held in place manually. Skin temperature was regularly measured and maintained between 32°C and 34°C throughout the electromyography session, thereby preventing any decrease in CMAP amplitude by muscle warming. The electrodes were stuck tightly enough to the skin to prevent displacement of the electrodes or changes in muscle volume during the ETs.
CMAPs were first monitored every 10 seconds for 1-2 minutes before exercise to allow baseline stabilization. The subjects were then asked to contract the muscle as strongly as possible for 5 minutes. Subjects were allowed a brief (3-4 seconds) resting periods every 30-45 seconds to prevent ischemia. After completion of the exercise, patients were instructed to completely relax while CMAPs were recorded for 2 seconds immediately after cessation of exercise, then every 5 minutes for 10 minutes, and finally every 10 minutes for 50 minutes. If the response changed and stimulation evoked submaximal response amplitudes, electrode placement was carefully examined to be sure lack of movement. We measured the baseline to peak negative amplitude for each CMAP. Percent decreased in CMAP amplitude was calculated by the following equation: Decrease = (baseline amplitude before exercise − smallest amplitude after exercise) / baseline amplitude × 100%.
Statistical analysis
We described continuous variables as mean ± SD. We used the Student's t test or analysis of variance (ANOVA) test for non-paired samples of normally distributed parameters and the Wilcoxon or Kruskal-Wallis rank test for nonparametric variables. The chi-squared test was applied for the comparison of categorical variables. ROC curve was used to identify the threshold for PPs diagnosis. P values <0.05 were considered statistically significant. All statistical analyses were used SPSS 18.0 software (SPSS Inc., USA).
RESULTS
ET results in the healthy subjects group
The 108 healthy volunteers came from various provinces of China. They had various occupations, including doctors, students, cleaners, and security guards. Their ages ranged from 14 to 57 years old. We recruited four times more men than women (87 man/21 women) because the PPs were more easily identified in men.
Standardized protocols for long-time ETs were applied to the 108 healthy subjects. Before the ET, CMAP amplitudes were stable. During or soon after exercise, CMAP amplitudes increased slightly. Subsequently, the CMAP amplitudes fell below the pre-exercise levels, but amplitudes returned to the baseline values within 20 minutes.
The maximum percent decrease in amplitude was 57%, and the minimum percent change was 0. The mean percent decrease in CMAP amplitude following exercise was 15.21%, with a SD of 12.69%.
In order to study the factors affecting change in CMAP amplitude, we analyzed the values among various groups of healthy subjects (Table 1) . For all 108 healthy subjects, the mean percent decrease in amplitude showed a trend toward being reduced among subjects in the older age groups; however, the magnitude of reduction in CMAP amplitude was not significantly different among the five age groups (P >0.05). In the higher and heavier groups, the decreases appeared larger. But they were not significant differences (P >0.05). The percent decrease in amplitude was larger among the group tested at 2 p.m.; however, there was no significant among the five groups of test time (P >0.05). Males had a larger decrease in amplitude than females following exercise (P=0.065). When the eight abnormal values were eliminated, there was no significant difference in percent decrease in CMAP amplitude between males and females (P=0.278).
Eight subjects showed a decrease of more than 41% of preexercise amplitudes. Based on the literatures, amplitude decrease more than 41% means ET abnormal. In order to confirm our ET results, we performed a secondary test on the eight subjects several days later. The left ADM muscle (the opposite side from the first test) was used to record from. Upon this test, abnormal results were still obtained for these subjects. In the first ET the mean percent decrease in amplitude was 48.38%, while in the second test the mean percent decrease was 46.60%.
We considered the possibility that the eight persons were asymptomatic PPs, so we performed molecular genetic tests to identify whether they carry mutations. We screened for the known mutations in PPs, including coding regions of the SCN4A and CACNA1S genes based on sequences found on the Human Gene Mutation Database (HGMD, http://www.hgmd.cf.ac.uk/ac/index.php). We found no such mutations in any of the eight persons.
ET results in the PPs patients group CMAP amplitudes from the PPs patients were mostly stable before the ET. After exercise, CMAP amplitudes in PPs patients increased to a greater extent than in healthy subjects. The CMAP amplitude also fell to a greater extent than in healthy subjects but did not return to baseline amplitudes within 50 minutes.
In the PPs group, the maximum percent decrease in amplitude was 92% and the minimum was 16% with mean percent decrease CMAP amplitude of 57.76% and SD of 16.41%, respectively.
ET results in the other patients group
In the other patients group, the maximum percent decrease in amplitude was 69%, the minimum was 0, the mean was 18.10%, and the SD was 13.39%. In five MG patients, the amplitude decreases were from 3% to 22%. Two LEMS patients' decreases were 14% and 19% separately. Two polymyosistis patients' decreases were 10% and 11%. Four GBS had decreases from 1% to 17%, however, one GBS had decrease of 67%. The decrease of the ALS patients was 33%. In two TIA patients, one decrease was 15%, the other was 67%. In most of the anxiety disorder patients, the decreases were normal, except one had decrease of 32%.
In patients with PPs, the CMAP amplitude decreased significantly more than in healthy subjects (57.76% and 15.21%; P <0.001) and other patients (57.76% and 18.10%; P <0.001). There was no significantly difference between patients with other diseases and healthy adults in the CMAP amplitude decrease (18.10% and 15.21%; P=0.752).
ROC curve analysis of the PPs and healthy groups showed the area under the curve was 0.965 that indicates ET is a good test to distinguish PPs patients from healthy adults (P <0.001). If a threshold of 35.5% decrease in CMAP amplitude was chosen, the diagnosis sensitivity was 92.6% and specificity was 92.6%. Compared with the PPs group and other patients group, the area under the curve was 0.946 that also indicates ET is a good test to distinguish PPs patients from other patients (P <0.001). If a threshold of 35.5% was chosen, the sensitivity was 92.6% and specificity was 94.4% (Figure 1 ). appear normal when not having an attack. For this reason, diagnosis of PPs is often difficult. Because PPs is a hereditary disease, many thought that DNA tests are the gold standard and best workup to diagnose. However, from a clinical point of view, DNA testing has certain shortcomings. First of all, the positive rate of mutation was very low because many of PPs patients had no family histories. Other shortcomings including, DNA testing may require several weeks to obtain results, the mutation cannot always be identified in some families, paralytic attacks are sometimes secondary to acquired diseases, and, in some regions, the cost of analysis may be prohibitively high.
DISCUSSION
PPs are episodic disorders of muscles, although patients
A lot of provocative tests were used to help diagnose PPs. Compared to administration of potassium and bicycle exercise, the long exercise test (ET) is safer and more effective. 1 However, the reference range of ET varies in different articles. In addition, the numbers of controls in these studies were small. In our study, we observed a large number of healthy adults and analyzed several factors affecting ET.
The ET reflected the function of muscle membrane excitability. 15 PPs may be induced by many factors, such as vigorous exercise, carbohydrate-rich meals, viral illness, and lack of sleep. We wonder if ET results may be also affected by other factors, including age, gender, weight, height, and test time. In our study, values between groups had no significant differences. So we believe that ET will not affected by the factors above.
Findings from eight subjects (7.40%) were abnormal among all 108 healthy adults. We performed a second ET on these eight subjects, and results remained abnormal. We therefore considered whether there was a reason that these eight subjects showed abnormal results. Blood tests from all eight subjects excluded hyperthyroidism and secondary hypokalemic syndrome. PPs are thought to be autosomal dominantly inherited. In patients with a clinical presentation consistent with hypokalemic periodic paralysis (HypoKPP), 64% of the kindreds had mutations in either the calcium channel or sodium channel. The majority were secondary to calcium channel mutations with R528H accounting for 42% of the mutations, and R1239H accounting for 42% of the mutations. For HyperKPP, sodium channel mutations were found in 64%. Of these mutations, 33% were T704M, 33% M1592V, 33% other sodium channel mutations. 10 We screened all of the known mutations in PPs, including coding regions of the SCN4A and CACNA1S genes. However, we found no mutations in the eight abnormal subjects. In a study by Kuntzer et al, 13 one healthy subject showed a decrease in CMAP amplitude of greater than 40% (2.17%, 1/46). Therefore, we conclude that ET results may be abnormal in some healthy adults.
In patients with thyrotoxic PP, the CMAP amplitude decrease after exercise is also significantly larger than healthy adults. 4 We found many neuromuscular diseases which need differential diagnoses of PPs have normal result in ET. The CMAP amplitude decreases were normal in MG patient. The possible reason may be that the function of muscle membrane excitability recovered so quickly. One of the five GBS had a large decrease of 67% while others had small decreases (1%-17%). We thought GBS might have abnormal results in ET but more patients should be studied. We do not know why two TIA patients had decreases. Maybe it is by coincidence, after all, there are 8% health had abnormal decreases.
This is a relatively early study using the ROC curve analysis to define the ET reference range. In other studies, normal ET results were defined as ±2 SDs of the mean for controls. ROC curve analysis is mainly used for diagnostic studies in Clinical Chemistry, Pharmacology and Physiology. It has been widely accepted as the standard for describing and comparing the accuracy of diagnostic tests. By choosing different cut-off point, lots of pairs of sensitivity and specificity values are accepted and used to draw a curve, which is ROC curve. When the sensitivity and specificity are maximized, this choosing cut-off point is the threshold. Then we can use this threshold as a reference range.
We designed two ways to analyze the ROC curve. First, we compared results from the PPs group and the healthy adults group. We found that an amplitude decrease of greater than 35.50% provided the best sensitivity and specificity in diagnosis of PP. Interestingly, when results from the PPs group were compared to patients with other disease group, the threshold for the decrease in amplitude was also 35.50%. Maybe it is because there was no significant difference between patients with other diseases and healthy adults in the CMAP amplitude decrease (P=0.752). So we believed the amplitude decrease of 35.50% is the threshold and the reference range of ET is amplitude decrease less than 35.50% after exercises.
In conclusion, we performed ETs in 108 healthy adults from various provinces of China and with various occupations. We found that age, gender, test time, and height did not significantly influence ET results. Some healthy adults may have abnormal results in the ET; the rate of abnormality in this study was 7.40% of subjects. We also observed patients with other diseases that may be easily confused for PPs, and we identified the ET reference range for PPs diagnosis by ROC curve. We conclude that a CMAP amplitude decrease after exercise of greater than 35.50% is abnormal.
